MYC and neoplasm: Accumulating evidence has demonstrated that the tumor suppressor functions of Smads are compromised by oncogene products, such as c-Ski, Bcl6, c-Myc, Evi-1 and STAT3, through direct Smad–oncoprotein interactions during carcinogenesis [47–50].